Cargando…
Is NMR Fragment Screening Fine-Tuned to Assess Druggability of Protein–Protein Interactions?
[Image: see text] Modulation of protein–protein interactions (PPIs) with small molecules has been hampered by a lack of lucid methods capable of reliably identifying high-quality hits. In fragment screening, the low ligand efficiencies associated with PPI target sites pose significant challenges to...
Autores principales: | Dias, David M., Van Molle, Inge, Baud, Matthias G. J., Galdeano, Carles, Geraldes, Carlos F. G. C., Ciulli, Alessio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2013
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3891296/ https://www.ncbi.nlm.nih.gov/pubmed/24436777 http://dx.doi.org/10.1021/ml400296c |
Ejemplares similares
-
Structure-Guided Design and
Optimization of Small
Molecules Targeting the Protein–Protein Interaction between
the von Hippel–Lindau (VHL) E3 Ubiquitin Ligase and the Hypoxia
Inducible Factor (HIF) Alpha Subunit with in Vitro Nanomolar Affinities
por: Galdeano, Carles, et al.
Publicado: (2014) -
Surface Probing
by Fragment-Based Screening and Computational
Methods Identifies Ligandable Pockets on the von Hippel–Lindau
(VHL) E3 Ubiquitin Ligase
por: Lucas, Xavier, et al.
Publicado: (2018) -
Selectivity on-target of bromodomain chemical probes by structure-guided medicinal chemistry and chemical biology
por: Galdeano, Carles, et al.
Publicado: (2016) -
Targeting Low-Druggability
Bromodomains: Fragment
Based Screening and Inhibitor Design against the BAZ2B Bromodomain
por: Ferguson, Fleur M., et al.
Publicado: (2013) -
NMR approaches in structure-based lead discovery: Recent developments and new frontiers for targeting multi-protein complexes
por: Dias, David M., et al.
Publicado: (2014)